Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
573 studies found for:    Open Studies | "Hematopoietic Stem Cells"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hematopoietic Stem Cells"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pilot Study Using Propranolol To Promote Prenylation Of The Gtpase Rap1b In Hematopoietic Stem Cell Transplant Recipients
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Blood Draw
2 Recruiting Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Allogeneic Hematopoietic Stem Cell
Interventions: Biological: fecal microbiota transplantation (FMT);   Other: No fecal microbiota transplantation (FMT), routine management
3 Recruiting Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers
Condition: Post Hematopoietic Stem Cell Transplantation
Intervention: Behavioral: semi-structured interviews
4 Recruiting Dose Finding Study of Vedolizumab for Graft-Versus-Host Disease (GvHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation
Intervention: Drug: Vedolizumab
5 Recruiting T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplant;   Poor Marrow Graft Function
Interventions: Procedure: Donor peripheral blood progenitor cells: stimulation, harvesting, isolation and T-cell depletion;   Device: CliniMACS Cell Selection System
6 Recruiting Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
Condition: Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Interventions: Biological: Recipients;   Biological: Donors
7 Recruiting Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
Conditions: Term and Preterm Neonates (24-41 Weeks Gestational Age);   Hematopoietic Stem Cell Transplant Recipient Children
Interventions: Other: Tubes fund recovery blood count;   Other: the rest of the blood test and stool sample
8 Recruiting Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Conditions: Leukemia, Myeloid, Acute;   Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intervention: Procedure: Haploidentical Stem Cell Transplantation
9 Recruiting Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: ATG
10 Recruiting Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Other: Data Collection
11 Recruiting Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant
Conditions: Hematopoietic Stem Cell Transplantation;   Stem Cell Transplantation, Hematopoietic;   Transplantation, Hematopoietic Stem Cell
Intervention:
12 Recruiting A Pharmacokinetic Study of Melphalan in Children
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: Melphalan
13 Recruiting A Multi-Institutional Phase II Feasibility Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Conditions: Neuroepithelial Tumor;   Solid Tumor;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Procedure: Allogeneic hematopoietic stem cell transplant following thiotepa-based marrow ablative chemotherapy;   Drug: Keratinocyte Growth Factor;   Drug: Alemtuzumab;   Drug: Thiotepa;   Drug: Etoposide;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Tacrolimus;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil
14 Not yet recruiting Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
Conditions: Acute Myeloid Leukemia;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Sorafenib
15 Recruiting Gut Decontamination In Pediatric Allogeneic Hematopoietic
Conditions: Hematopoietic Stem Cell Transplantation (HSCT);   Acute GVH Disease
Intervention: Drug: Vancomycin-polymyxin B
16 Recruiting Intrabone Infusion of Umbilical Cord Blood Stem Cells
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Procedure: Intrabone infusion of umbilical cord blood stem cells
17 Recruiting Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
Conditions: Hematopoietic Stem Cell Transplantation;   Vancomycin-Resistant Enterococci
Interventions: Other: Theraworx™ bath wipes;   Other: Standard bath wipes
18 Recruiting TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
Conditions: Primary Immune Deficiency Disorder;   Hematopoietic Stem Cell Transplantation
Intervention: Other: Biological: TCR alfa beta T cell depletion
19 Not yet recruiting Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT
Conditions: Myelodysplastic Syndrome;   Allogeneic Hematopoietic Stem Cell Transplantation
Interventions: Drug: Decitabine;   Drug: CAG chemotherapy regimen;   Drug: G-CSF+Decitabine+BUCY Conditioning Regimen
20 Recruiting Hemostatic Complications in Hematopoietic Stem Cell Transplantation
Condition: Hemostatic Disorders
Intervention: Drug: thrombopoietin, interleukin-11, heparin,

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.